Sun Pharmaceuticals’ drug manufacturing plant in Gujarat, India, received an import alert from the FDA Dec. 7, which could threaten the drugmakers’ ability to ship drugs to the U.S.
Read the full post on Becker's Hospital Review - Healthcare News
Sun Pharma plant may be barred from shipping drugs to US
